Level Four Advisory Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,076
| Closed | -$220K | – | 910 |
|
|
2024
Q1 | $220K | Buy |
3,076
+80
| +3% | +$5.73K | 0.01% | 696 |
|
|
2023
Q4 | $215K | Buy |
+2,996
| New | +$215K | 0.01% | 701 |
|
|
2023
Q3 | – | Sell |
-7,483
| Closed | -$474K | – | 866 |
|
|
2023
Q2 | $474K | Buy |
+7,483
| New | +$474K | 0.03% | 484 |
|
|
2023
Q1 | – | Sell |
-7,052
| Closed | -$373K | – | 824 |
|
|
2022
Q4 | $373K | Sell |
7,052
-398
| -5% | -$21.1K | 0.03% | 466 |
|
|
2022
Q3 | $347K | Sell |
7,450
-6,975
| -48% | -$325K | 0.03% | 392 |
|
|
2022
Q2 | $823K | Sell |
14,425
-237
| -2% | -$13.5K | 0.08% | 250 |
|
|
2022
Q1 | $897K | Buy |
+14,662
| New | +$897K | 0.07% | 263 |
|